New pill aims to tame severe eczema Flare-Ups
NCT ID NCT05526222
Summary
This study is testing whether an oral medication called jaktinib can help control moderate to severe atopic dermatitis, a form of eczema. It will compare the drug to a placebo in 443 adults to see if it significantly improves skin symptoms and is safe. The goal is to provide a new long-term treatment option to manage this chronic skin condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
139 People's Middle Road
Changsha, Hunan, 410008, China
Conditions
Explore the condition pages connected to this study.